The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans

This study has been completed.
Sponsor:
Information provided by:
Committee on Chinese Medicine and Pharmacy
ClinicalTrials.gov Identifier:
NCT00329212
First received: May 23, 2006
Last updated: November 14, 2006
Last verified: November 2006
  Purpose

The purpose of this study is to investigate the pharmacokinetics in humans of San Huang Xie Jin Tang (SHXJT) and evaluate the bioequivalence between herbal concentrate and traditional decoction.


Condition Intervention
Healthy
Drug: San Huang Xie Jin Tang

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Bioequivalence of Bioactive Markers Between Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans

Further study details as provided by Committee on Chinese Medicine and Pharmacy:

  Eligibility

Ages Eligible for Study:   20 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The volunteers about 6~8 persons should be aged from 20 to 35 years old with a body weight between 50~80 kg, no marriage and have a healthy body condition.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00329212

Locations
China, Taiwan
Committee on Chinese Medicine and Pharmacy, Department of Health
Taipei, Taiwan, China
Sponsors and Collaborators
Committee on Chinese Medicine and Pharmacy
Investigators
Principal Investigator: Y C Hou, Professor School of Chinese Medicine, China Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00329212     History of Changes
Other Study ID Numbers: CCMP95-RD-010
Study First Received: May 23, 2006
Last Updated: November 14, 2006
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Committee on Chinese Medicine and Pharmacy:
Pharmacokinetics
Bioavailability
Therapeutic Equivalency

ClinicalTrials.gov processed this record on September 16, 2014